Abstract
Meeting abstracts Engineering T cells with chimeric antigen receptors (CARs) is proving to be an effective method for directing T cells to attack tumors in an MHC-independent manner. Current generation CARs aim to recapitulate T cell signaling by incorporating modular functional components of the
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have